TMDX: Strategic investments and new platforms aim to double market reach and accelerate growth by 2027
The company highlighted robust revenue growth, a unique integrated business model, and strategic investments in heart, lung, and kidney transplant markets. Expansion into Europe and the launch of OCS 3.0 are set to double the addressable market, with 2027 positioned as a key inflection year.Based o…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.